A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors

Noelle K. Loconte, Albiruni R.A. Razak, Percy Ivy, Amye Tevaarwerk, Rachael Leverence, Jill Kolesar, Lillian Siu, Sam J. Lubner, Daniel L. Mulkerin, William R. Schelman, Dustin A. Deming, Kyle D. Holen, Lakeesha Carmichael, Jens Eickhoff, Glenn Liu

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science